Revenue Cycle Matters

pexels tima miroshnichenko

Potential Changes to Telehealth Visits

The global COVID-19 pandemic has brought an emerging healthcare technology to every-day practice nearly overnight. Two years ago, telehealth was something new that many practices were shying away from. Once the pandemic took over, they became a literal virtual necessity. Before the pandemic, legislation required many telehealth visits to still occur in a medical facility […]

Potential Changes to Telehealth Visits Read More »

site neutral payments

Site-Neutral Payments Supported by Federal Court

In a ruling last week, a Federal appeals Court ruled that the Department of Health & Human Services (HHS) is authorized to implement site-neutral payments. This is a long-awaited and huge win for independent physician practices. Historically, off-campus clinics attached to a hospital were reimbursed at a higher rate than independent physician practices. This left

Site-Neutral Payments Supported by Federal Court Read More »

Price Transparency Updates

Update to Regulations for Price Transparency

Over the summer we discussed in a blogpost, “Executive Order Reduces HHS Time for Transparency,” the order issues from the current administration to make pricing more accessible for patients to be able to shop around for common outpatient procedures. November 15th, CMS announced two proposed regulations intended to follow through on this order. One is

Update to Regulations for Price Transparency Read More »

drugmakers

Ruling Against First Pharmaceutical Company in Opioid Lawsuit

For the first time, a pharmaceutical company, Johnson & Johnson, has been ordered to pay a substantial sum for their role in the opioid crisis in Oklahoma. While the opioid epidemic is no doubt a nationwide crisis, Oklahoma has been particularly devastated by the highly addictive pain killer. There have reportedly been over 6,000 deaths

Ruling Against First Pharmaceutical Company in Opioid Lawsuit Read More »